In our study, NOTCH1 mutations were found in 43.8% of BCC lesions and were mainly inactivating alterations, which support the tumour-suppressor role of NOTCH1 in BCC tumorigenesis. This evidence concerns the gene NOTCH1 and skin basal cell carcinoma.